Effectiveness of Ledipasvir-Sofosbuvir Combination in Patients With Hepatitis C Virus Infection and Factors Associated With Sustained Virologic Response

BACKGROUND & AIMS: The combination of ledipasvir and sofosbuvir has been approved for treatment of genotype 1 hepatitis C virus (HCV) infection, including an 8-week regimen for treatment-naïve patients without cirrhosis and a baseline level of HCV RNA <6 million IU/mL. We analyzed data from a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Gastroenterology
Main Authors: Terrault, Norah A., Zeuzem, Stefan, Di Bisceglie, Adrian M., Lim, Joseph K., Pockros, Paul J., Frazier, Lynn M., Kuo, Alexander, Lok, Anna S., Shiffman, Mitchell L., Ben Ari, Ziv, Akushevich, Lucy, Vainorius, Monika, Sulkowski, Mark S., Fried, Michael W., Nelson, David R.
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5300778/
https://ncbi.nlm.nih.gov/pubmed/27565882
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.gastro.2016.08.004
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados